$2.12
-0.04[-1.85%]
At close: Apr 23
$2.12
0[0.00%]
After Hours: 8:36AM EDT
Emergent BioSolutions reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Emergent BioSolutions using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/01/2024 | PM | EBS | Q1 | -$3.17 | -$0.62 | — | — | $165.10M | $224.50M | — | — | Get Alert |
03/06/2024 | PM | EBS | Q4 | -$0.31 | -$0.19 | -$0.77 | -305.26% | $330.70M | $293.53M | $276.60M | -5.77% | Get Alert |
11/08/2023 | PM | EBS | Q3 | -$1.27 | -$0.22 | -$0.87 | -295.45% | $240.00M | $237.43M | $270.50M | 13.93% | Get Alert |
08/08/2023 | PM | EBS | Q2 | -$0.86 | -$0.47 | -$1.06 | -125.53% | $242.70M | $217.03M | $337.90M | 55.69% | Get Alert |
05/09/2023 | PM | EBS | Q1 | $0.18 | -$1.24 | -$3.17 | -155.65% | $307.50M | $143.28M | $165.10M | 15.23% | Get Alert |
02/27/2023 | PM | EBS | Q4 | $4.50 | $0.04 | -$0.31 | -875.00% | $723.20M | $296.62M | $330.70M | 11.49% | Get Alert |
11/08/2022 | PM | EBS | Q3 | -$0.36 | -$0.06 | -$1.27 | -2016.67% | $329.00M | $268.30M | $240.00M | -10.55% | Get Alert |
08/01/2022 | PM | EBS | Q2 | $0.33 | $0.37 | -$0.86 | -332.43% | $397.50M | $270.94M | $242.70M | -10.42% | Get Alert |
04/28/2022 | PM | EBS | Q1 | $1.53 | $0.12 | $0.18 | 50.00% | $343.00M | $283.00M | $307.50M | 8.66% | Get Alert |
02/24/2022 | PM | EBS | Q4 | $3.67 | $4.27 | $4.50 | 5.39% | $583.00M | $691.36M | $723.20M | 4.61% | Get Alert |
11/04/2021 | PM | EBS | Q3 | $2.19 | $2.35 | -$0.36 | -115.32% | $385.20M | $486.84M | $329.00M | -32.42% | Get Alert |
07/29/2021 | PM | EBS | Q2 | $1.98 | $1.54 | $0.33 | -78.57% | $394.70M | $398.93M | $397.50M | -0.36% | Get Alert |
04/29/2021 | PM | EBS | Q1 | $0.01 | $1.12 | $1.53 | 36.61% | $192.50M | $358.47M | $343.00M | -4.32% | Get Alert |
02/18/2021 | PM | EBS | Q4 | $1.57 | $3.19 | $3.67 | 15.05% | $360.40M | $563.60M | $583.00M | 3.44% | Get Alert |
11/05/2020 | PM | EBS | Q3 | $1.21 | $2.12 | $2.19 | 3.30% | $311.80M | $437.93M | $385.20M | -12.04% | Get Alert |
07/30/2020 | PM | EBS | Q2 | -$0.12 | $0.64 | $1.98 | 209.38% | $243.20M | $294.73M | $394.70M | 33.92% | Get Alert |
04/30/2020 | PM | EBS | Q1 | -$0.13 | $0.01 | $0.01 | 0.00% | $190.60M | $199.47M | $192.50M | -3.49% | Get Alert |
02/20/2020 | PM | EBS | Q4 | $0.75 | $1.73 | $1.57 | -9.25% | $270.70M | $358.70M | $360.40M | 0.47% | Get Alert |
11/06/2019 | PM | EBS | Q3 | $0.55 | $0.90 | $1.21 | 34.44% | $173.65M | $289.27M | $311.80M | 7.79% | Get Alert |
Emergent BioSolutions (EBS) is scheduled to report earnings on May 1, 2024. The last reported earnings were for reported on March 6, 2024 for Q4.
The Actual EPS was $-0.77, which missed the estimate of $-0.19.
The Actual Revenue was $276.6M, which missed the estimate of $293.5M.
Browse earnings estimates, EPS, and revenue on all stocks.